Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pulmonx Corp

3.34
+0.02500.75%
Post-market: 3.340.00000.00%16:11 EDT
Volume:254.37K
Turnover:843.32K
Market Cap:134.46M
PE:-2.31
High:3.41
Open:3.32
Low:3.20
Close:3.32
Loading ...

3 Penny Stocks Under $300M Market Cap To Consider

Simply Wall St.
·
22 Jul

Lake Street Remains a Buy on Pulmonx (LUNG)

TIPRANKS
·
21 Jul

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

GlobeNewswire
·
17 Jul

Pulmonx Director Cashes In on Stock Sale!

TIPRANKS
·
14 Jun

Director Richard Ferrari Reports Disposal of Common Shares of Pulmonx Corporation

Reuters
·
14 Jun

Director Florin Daniel P Reports Acquisition of Common Shares in Pulmonx Corporation

Reuters
·
06 Jun

General Counsel David Aaron Lehman Reports Disposal of Pulmonx Corporation Common Shares

Reuters
·
05 Jun

Pulmonx: Balancing Growth Potential and Financial Challenges with a Hold Rating

TIPRANKS
·
30 May

Pulmonx Corporation to Present at Goldman Sachs 46th Annual Global Healthcare Conference in Miami

Reuters
·
29 May

Pulmonx Corporation Concluded Annual Stockholders Meeting

Reuters
·
23 May

Pulmonx Is Maintained at Neutral by Citigroup

Dow Jones
·
23 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pulmonx (LUNG) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
05 May

Pulmonx Corporation’s Earnings Call Highlights Growth and Challenges

TIPRANKS
·
02 May

Pulmonx Price Target Cut to $9.00/Share From $10.00 by Piper Sandler

Dow Jones
·
01 May

Q1 2025 Pulmonx Corp Earnings Call

Thomson Reuters StreetEvents
·
01 May

Pulmonx Is Maintained at Buy by D. Boral Capital

Dow Jones
·
01 May

Pulmonx price target lowered to $9 from $10 at Piper Sandler

TIPRANKS
·
01 May

Piper Sandler Sticks to Their Buy Rating for Pulmonx (LUNG)

TIPRANKS
·
01 May

Pulmonx Corporation Reports Strong Q1 2025 Results

TIPRANKS
·
01 May

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May